KAY CHRISTINA 4
4 · INTEGRATED BIOPHARMA INC · Filed May 22, 2025
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-05-21−144,445→ 0 totalExercise: $0.09Exp: 2025-06-02→ Common Stock (144,445 underlying) - Award
Common Stock
2025-05-21$0.09/sh+144,445$13,000→ 1,473,467 total
Footnotes (2)
- [F1]144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
- [F2]81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.